PAVmed (PAVM) Enterprise Value (2016 - 2026)

PAVmed has reported Enterprise Value for 11 years, with the latest figure at $119.5 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 62.29% year-over-year to $119.5 million in Q2 2026; TTM through Jun 2026 was $119.5 million, a 62.29% decrease from a year earlier, with the FY2025 full-year figure at -$8.8 million, down 102.48% from the prior year.
• Enterprise Value was $119.5 million for Q2 2026 at PAVmed, up from -$8.8 million in the prior quarter.
• The five-year high for Enterprise Value was $3.4 billion in Q1 2022, with the low at -$8.8 million in Q4 2025.
• Average Enterprise Value over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 76.31% in 2023, then sank 102.48% in 2025.
• Over 5 years, Enterprise Value stood at $1.3 billion in 2022, then soared by 76.31% to $2.4 billion in 2023, then slumped by 85.08% to $353.1 million in 2024, then tumbled by 102.48% to -$8.8 million in 2025, then soared by 1464.05% to $119.5 million in 2026.
• The last three Enterprise Value figures came in at $119.5 million (Q2 2026), -$8.8 million (Q4 2025), and $256.2 million (Q3 2025), per Business Quant data.